Parenteral Nutrition Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2030

Parenteral Nutrition Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals), and End User (Hospitals, Clinics, and Others) and Geography

  • Report Code : TIPRE00005217
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Buy Now

Parenteral Nutrition Market Forecast (2023-2030)

Buy Now

The parenteral nutrition market size is projected to reach US$ 11.12 billion by 2030 from US$ 6.84 billion in 2022. The market is expected to register a CAGR of 6.0% during 2022–2030. Innovation in the formulation of nutrition products will likely remain a key trend in the market.

Parenteral Nutrition Market Analysis

The rising prevalence of gastrointestinal diseases and surge in cases of malnutrition and premature births and are the key driving factors behind the market development. Furthermore, the innovation in formulations of nutrition products is a crucial opportunity for the parenteral nutrition market players.

Parenteral Nutrition Market Overview

Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe. Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. China (911,405) and the US (762,890) registered the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Ulcerative colitis and Crohn’s disease are two of the commonly diagnosed IBDs. Crohn’s disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America and Europe.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Parenteral Nutrition Market: Strategic Insights

parenteral-nutrition-market
Market Size Value inUS$ 6.84 billion in 2022
Market Size Value byUS$ 11.12 billion by 2030
Growth rateCAGR of 6.0% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Parenteral Nutrition Market Drivers and Opportunities

Surge in Cases of Malnutrition and Premature Births

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). Furthermore, ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.

New Product Developments by Companies

Companies operating in the parenteral medical nutrition market constantly focus on new product launches, which help them improve their sales. A few of the noteworthy developments in the parenteral nutrition market are mentioned below:

  • In December 2022, Baxter International Inc introduced the ExactaMix Pro Automated Compounder in the US. The announcement was made at the 2022 Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP). The product debuted at the beginning of 2023. The recently released product makes use of cutting-edge compounding technology to enhance patient safety, process effectiveness, and formulation accuracy.
  • In March 2022, Fresenius Kabi’s SMOFlipid lipid injectable emulsion received US Food and Drug Administration (FDA) approval. The emulsion is used to provide parenteral nutrition to pediatric patients, including term and preterm neonates, which makes it the first and only four-oil lipid emulsion for pediatric patients requiring parenteral nutrition.

Thus, new product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.

Parenteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the parenteral nutrition market analysis are offerings, usage, and end user.

  • Based on nutrient type, the parenteral nutrition market is segmented into single-dose amino acid solutions, parenteral lipid emulsion, carbohydrates, trace elements, vitamins and minerals. The single dose amino acid solution segment held a most significant market share in 2022.
  • Based on end users, the parenteral nutrition market is segmented by hospitals, clinics, others. The hospitals segment held a largest market share in 2022.

Parenteral Nutrition Market Share Analysis by Geography

The geographic scope of the parenteral nutrition market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

In North America, the US parenteral nutrition market holds the largest share of the region. Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. According to an article titled “Trends in Parenteral Nutrition,” published in January 2019; on average, ~34,000 patients receive parenteral nutrition (PN) annually in the US. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

Parenteral Nutrition Market Report Scope

Parenteral Nutrition Market News and Recent Developments

The Parenteral Nutrition Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the parenteral nutrition market are listed below:

  • Baxter International Inc. received U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) nutrition (PN) when oral or enteral nutrition is not possible, insufficient or contraindicated. Clinolipid has been available in the U.S. for adults since 2019 and is now available for use in all ages. (Source: Baxter International Inc., Company Website, January 2020)

Parenteral Nutrition Market Report Coverage and Deliverables

The “Parenteral Nutrition Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

  • Parenteral nutrition market  size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Parenteral nutrition market  trends as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Parenteral nutrition market  analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the parenteral nutrition market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Nutrient Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

Which are the leading players operating in the parenteral nutrition market?

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, Vifor Pharma Management AG.

What is the expected CAGR of the parenteral nutrition market?

The market is expected to register a CAGR of 6.0% during 2022–2030.

Which region dominated the parenteral nutrition market in 2022?

North America dominated the parenteral nutrition market in 2022

What are the driving factors impacting the carboxy therapy market?

The rising prevalence of gastrointestinal diseases and surge in cases of malnutrition and premature births and are the key driving factors behind the market development. However, mechanical, gastrointestinal, and metabolic complications associated with parenteral feeding systems are hampering the market growth.

What are the future trends of the parenteral nutrition market?

Innovation in formulations of nutrition products will likely remain a key trend in the market.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Parenteral Nutrition Market, by Geography (US$ Million)

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Parenteral Nutrition Market Landscape

4.1 Overview

4.2 Global PEST Analysis

5. Parenteral Nutrition Market - Key Industry Dynamics

5.1 Market Drivers

5.1.1 Rise in Prevalence of Gastrointestinal Diseases

5.1.2 Surge in Cases of Malnutrition and Premature Births

5.2 Market Restraints

5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems

5.3 Market Opportunities

5.3.1 New Product Developments by Companies

5.4 Future Trends

5.4.1 Innovation in Formulations of Nutrition Products

5.5 Impact Analysis

6. Parenteral Nutrition Market - Global Market Analysis

6.1 Parenteral Nutrition Market Revenue (US$ Mn), 2022 – 2030

7. Parenteral Nutrition Market Analysis – by Nutrient Type

7.1 Overview

7.2 Single Dose Amino Acid Solution

7.2.1 Overview

7.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

7.3 Parenteral Lipid Emulsion

7.3.1 Overview

7.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

7.4 Carbohydrates

7.4.1 Overview

7.4.2 Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

7.5 Trace Elements

7.5.1 Overview

7.5.2 Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

7.6 Vitamins and Minerals

7.6.1 Overview

7.6.2 Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

8. Parenteral Nutrition Market Analysis – by End User

8.1 Overview

8.2 Hospitals

8.2.1 Overview

8.2.2 Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Clinics

8.3.1 Overview

8.3.2 Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Others

8.4.1 Overview

8.4.2 Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9. Parenteral Nutrition Market – Geographical Analysis

9.1 North America: Parenteral Nutrition Market

9.1.1 Overview

9.1.2 North America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.2.1 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type

9.1.2.2 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User

9.1.3 North America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country

9.1.3.1 United States: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.1.1 Overview

9.1.3.1.2 United States: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.1.3 United States: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.1.3.1.4 United States: Parenteral Nutrition Market Breakdown, by End User

9.1.3.2 Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.2.1 Overview

9.1.3.2.2 Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.2.3 Canada: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.1.3.2.4 Canada: Parenteral Nutrition Market Breakdown, by End User

9.1.3.3 Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.3.1 Overview

9.1.3.3.2 Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.3.3 Mexico: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.1.3.3.4 Mexico: Parenteral Nutrition Market Breakdown, by End User

9.2 Europe

9.2.1 Overview

9.2.2 Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.2.1 Europe: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type

9.2.2.2 Europe: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User

9.2.3 Europe: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country

9.2.3.1 Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.1.1 Overview

9.2.3.1.2 Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.1.3 Germany: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.2.3.1.4 Germany: Parenteral Nutrition Market Breakdown, by End User

9.2.3.2 United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.2.1 Overview

9.2.3.2.2 United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.2.3 United Kingdom: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.2.3.2.4 United Kingdom: Parenteral Nutrition Market Breakdown, by End User

9.2.3.3 France: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.3.1 Overview

9.2.3.3.2 France: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.3.3 France: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.2.3.3.4 France: Parenteral Nutrition Market Breakdown, by End User

9.2.3.4 Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.4.1 Overview

9.2.3.4.2 Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.4.3 Italy: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.2.3.4.4 Italy: Parenteral Nutrition Market Breakdown, by End User

9.2.3.5 Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.5.1 Overview

9.2.3.5.2 Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.5.3 Spain: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.2.3.5.4 Spain: Parenteral Nutrition Market Breakdown, by End User

9.2.3.6 Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.6.1 Overview

9.2.3.6.2 Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.6.3 Rest of Europe: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.2.3.6.4 Rest of Europe: Parenteral Nutrition Market Breakdown, by End User

9.3 Asia Pacific

9.3.1 Overview

9.3.2 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.2.1 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type

9.3.2.2 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User

9.3.3 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country

9.3.3.1 China: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.1.1 Overview

9.3.3.1.2 China: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.3.3.1.4 China: Parenteral Nutrition Market Breakdown, by End User

9.3.3.2 Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.2.1 Overview

9.3.3.2.2 Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.3.3.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User

9.3.3.3 India: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.3.1 Overview

9.3.3.3.2 India: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.3.3.3.4 India: Parenteral Nutrition Market Breakdown, by End User

9.3.3.4 Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.4.1 Overview

9.3.3.4.2 Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.3.3.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User

9.3.3.5 South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.5.1 Overview

9.3.3.5.2 South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.3.3.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User

9.3.3.6 Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.6.1 Overview

9.3.3.6.2 Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.3.3.6.3 Rest of APAC: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.3.3.6.4 Rest of APAC: Parenteral Nutrition Market Breakdown, by End User

9.4 Middle East and Africa

9.4.1 Overview

9.4.2 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.2.1 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type

9.4.2.2 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User

9.4.3 Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country

9.4.3.1 Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.1.1 Overview

9.4.3.1.2 Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.1.3 Saudi Arabia: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.4.3.1.4 Saudi Arabia: Parenteral Nutrition Market Breakdown, by End User

9.4.3.2 United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.2.1 Overview

9.4.3.2.2 United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.2.3 United Arab Emirates: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.4.3.2.4 United Arab Emirates: Parenteral Nutrition Market Breakdown, by End User

9.4.3.3 South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.3.1 Overview

9.4.3.3.2 South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.3.3 South Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.4.3.3.4 South Africa: Parenteral Nutrition Market Breakdown, by End User

9.4.3.4 Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.4.1 Overview

9.4.3.4.2 Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.4.3 Rest of Middle East and Africa: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.4.3.4.4 Rest of Middle East and Africa: Parenteral Nutrition Market Breakdown, by End User

9.5 South and Central America

9.5.1 Overview

9.5.2 The South & Central South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.2.1 South and Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Nutrient Type

9.5.2.2 South and Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by End User

9.5.3 South and Central America: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country

9.5.3.1 Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.3.1.1 Overview

9.5.3.1.2 Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.3.1.3 Brazil: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.5.3.1.4 Brazil: Parenteral Nutrition Market Breakdown, by End User

9.5.3.2 Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.3.2.1 Overview

9.5.3.2.2 Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.3.2.3 Argentina: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.5.3.2.4 Argentina: Parenteral Nutrition Market Breakdown, by End User

9.5.3.3 Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.3.3.1 Overview

9.5.3.3.2 Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

9.5.3.3.3 Rest of South and Central America: Parenteral Nutrition Market Breakdown, by Nutrient Type

9.5.3.3.4 Rest of South and Central America: Parenteral Nutrition Market Breakdown, by End User

10. Industry Landscape

10.1 Overview

10.1.1 Overview

11. Company Profiles

11.1 ICU Medical Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Grifols SA

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Pfizer Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Otsuka Pharmaceuticals Co Ltd

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Baxter International Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 B Braun SE

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Fresenius Kabi AG

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Vifor Pharma Management AG

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Aculife Healthcare Pvt Ltd

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. Parenteral Nutrition Market Segmentation

Table 2. North America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 3. North America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 4. United States: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 5. United States: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 6. Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 7. Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 8. Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 9. Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 10. Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 11. Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 12. Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 13. Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 14. United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 15. United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 16. France: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 17. France: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 18. Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 19. Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 20. Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 21. Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 22. Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 23. Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 24. Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 25. Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 26. China: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 27. China: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 28. Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 29. Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 30. India: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 31. India: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 32. Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 33. Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 34. South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 35. South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 36. Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 37. Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 38. Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 39. Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 40. Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 41. Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 42. United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 43. United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 44. South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 45. South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 46. Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 47. Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 48. South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 49. South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 50. Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 51. Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 52. Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 53. Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 54. Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type

Table 55. Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User

Table 56. Recent Organic Growth Strategies in the Parenteral Nutrition Market

Table 57. Glossary of Terms, Parenteral Nutrition Market

List of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Geography

Figure 2. Global North America - PEST Analysis

Figure 3. Parenteral Nutrition Market: Key Industry Dynamics

Figure 4. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints

Figure 5. Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030

Figure 6. Global Parenteral Nutrition Market, By Geography Forecast Analysis, 2022 & 2030

Figure 7. Parenteral Nutrition Market Share (%) – by Nutrient Type (2022 and 2030)

Figure 8. Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11. Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12. Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. Parenteral Nutrition Market Share (%) – by End User (2022 and 2030)

Figure 14. Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15. Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17. North America: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)

Figure 18. North America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 19. North America: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 20. United States: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 21. Canada: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 22. Mexico: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 23. Europe: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)

Figure 24. Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 25. Europe: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 26. Germany: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 27. United Kingdom: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 28. France: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 29. Italy: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 30. Spain: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 31. Rest of Europe: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 32. Asia Pacific: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)

Figure 33. Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 34. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 35. China: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 36. Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 37. India: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 38. Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 39. South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 40. Rest of APAC: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 41. Middle East & Africa: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)

Figure 42. Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 43. Middle East and Africa: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 44. Saudi Arabia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 45. United Arab Emirates: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 46. South Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 47. Rest of Middle East and Africa: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 48. South & Central America: Parenteral Nutrition Market, By Key Country – Revenue (2022) (US$ Million)

Figure 49. South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 50. South and Central America: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 51. Brazil: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 52. Argentina: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

Figure 53. Rest of South and Central America: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)

The List of Companies - Parenteral Nutrition Market

  1. ICU Medical Inc   
  2. Grifols SA               
  3. Pfizer Inc                
  4. Otsuka Pharmaceuticals Co Ltd
  5. Baxter International Inc   
  6. B Braun SE             
  7. Fresenius Kabi AG              
  8. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd  
  9. Vifor Pharma Management AG
  10. Aculife Healthcare Pvt Ltd            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..